Huang P, Xia M, Vago F, Jiang W, Tan M
Vaccines (Basel). 2024; 12(8).
PMID: 39203972
PMC: 11359793.
DOI: 10.3390/vaccines12080846.
Rehman S
Proc (Bayl Univ Med Cent). 2024; 37(5):851-857.
PMID: 39165802
PMC: 11332642.
DOI: 10.1080/08998280.2024.2372745.
Pei L, Hickman H
Viruses. 2024; 16(5).
PMID: 38793562
PMC: 11126121.
DOI: 10.3390/v16050679.
Peng F, Hu N, Liu Y, Xing C, Luo L, Li X
Front Microbiol. 2023; 14:1255935.
PMID: 37954238
PMC: 10634548.
DOI: 10.3389/fmicb.2023.1255935.
Tang D, Liu X, Lu J, Fan H, Xu X, Sun K
Front Immunol. 2023; 14:1203410.
PMID: 37435062
PMC: 10331816.
DOI: 10.3389/fimmu.2023.1203410.
A systematic review to identify novel clinical characteristics of monkeypox virus infection and therapeutic and preventive strategies to combat the virus.
Chenchula S, Ghanta M, Amerneni K, Rajakarunakaran P, Chandra M, Chavan M
Arch Virol. 2023; 168(7):195.
PMID: 37386209
DOI: 10.1007/s00705-023-05808-4.
Cowpox Viruses: A Zoo Full of Viral Diversity and Lurking Threats.
Bruneau R, Tazi L, Rothenburg S
Biomolecules. 2023; 13(2).
PMID: 36830694
PMC: 9953750.
DOI: 10.3390/biom13020325.
What a Transfusion Physician Should Know about Monkeypox Virus: Barriers to and Risks for Transmission, and Possible Mitigation Strategies.
Focosi D, Franchini M
Diagnostics (Basel). 2022; 12(9).
PMID: 36140601
PMC: 9497883.
DOI: 10.3390/diagnostics12092200.
Low-Temperature Multiple Micro-Dispensing on Microneedles for Accurate Transcutaneous Smallpox Vaccination.
Yim S, Hwang Y, An S, Seong K, Kim S, Kim S
Vaccines (Basel). 2022; 10(4).
PMID: 35455310
PMC: 9024753.
DOI: 10.3390/vaccines10040561.
Characterization of an In Vivo Neutralizing Anti-Vaccinia Virus D8 Single-Chain Fragment Variable (scFv) from a Human Anti-Vaccinia Virus-Specific Recombinant Library.
Diesterbeck U, Ahsendorf H, Frenzel A, Sharifi A, Schirrmann T, Czerny C
Vaccines (Basel). 2021; 9(11).
PMID: 34835240
PMC: 8619513.
DOI: 10.3390/vaccines9111308.
Imaging viral infection in vivo to gain unique perspectives on cellular antiviral immunity.
Vrba S, Hickman H
Immunol Rev. 2021; 306(1):200-217.
PMID: 34796538
PMC: 9073719.
DOI: 10.1111/imr.13037.
Single Immunization of a Vaccine Vectored by a Novel Recombinant Vaccinia Virus Affords Effective Protection Against Respiratory Syncytial Virus Infection in Cotton Rats.
Russell M, Thulasi Raman S, Gravel C, Zhang W, Pfeifle A, Chen W
Front Immunol. 2021; 12:747866.
PMID: 34603336
PMC: 8484905.
DOI: 10.3389/fimmu.2021.747866.
Fatal Cowpox Virus Infection in Human Fetus, France, 2017.
Ferrier A, Frenois-Veyrat G, Schvoerer E, Henard S, Jarjaval F, Drouet I
Emerg Infect Dis. 2021; 27(10):2570-2577.
PMID: 34352194
PMC: 8462324.
DOI: 10.3201/eid2710.204818.
Injection site vaccinology of a recombinant vaccinia-based vector reveals diverse innate immune signatures.
Hazlewood J, Dumenil T, Le T, Slonchak A, Kazakoff S, Patch A
PLoS Pathog. 2021; 17(1):e1009215.
PMID: 33439897
PMC: 7837487.
DOI: 10.1371/journal.ppat.1009215.
Replication-inducible vaccinia virus vectors with enhanced safety in vivo.
OConnell C, Jasperse B, Hagen C, Titong A, Verardi P
PLoS One. 2020; 15(4):e0230711.
PMID: 32240193
PMC: 7117657.
DOI: 10.1371/journal.pone.0230711.
Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments.
Noyce R, Lederman S, Evans D
PLoS One. 2018; 13(1):e0188453.
PMID: 29351298
PMC: 5774680.
DOI: 10.1371/journal.pone.0188453.
Genomic identification of human vaccinia virus keratoconjunctivitis and its importance as a laboratory-acquired infection.
Motlagh Z, Mokhtari A, Mahzounieh M
Indian J Ophthalmol. 2016; 64(11):806-812.
PMID: 27958202
PMC: 5200981.
DOI: 10.4103/0301-4738.195592.
Defending against smallpox: a focus on vaccines.
Voigt E, Kennedy R, Poland G
Expert Rev Vaccines. 2016; 15(9):1197-211.
PMID: 27049653
PMC: 5003177.
DOI: 10.1080/14760584.2016.1175305.
Therapeutic Vaccine Strategies against Human Papillomavirus.
Khallouf H, Grabowska A, Riemer A
Vaccines (Basel). 2015; 2(2):422-62.
PMID: 26344626
PMC: 4494257.
DOI: 10.3390/vaccines2020422.
Vaccine-induced protection against orthopoxvirus infection is mediated through the combined functions of CD4 T cell-dependent antibody and CD8 T cell responses.
Chaudhri G, Tahiliani V, Eldi P, Karupiah G
J Virol. 2014; 89(3):1889-99.
PMID: 25428875
PMC: 4300738.
DOI: 10.1128/JVI.02572-14.